| KU-55933 |
ENSG00000117242.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000124915.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000124915.6 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000131484.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000135253.9 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000135253.9 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000157306.10 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000157306.10 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000163597.10 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000164621.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000167912.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000170590.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000171889.3 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000172250.10 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000172965.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000175873.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000177640.11 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000177757.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000177993.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000179743.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000179859.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000180846.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000182109.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000182376.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000182586.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000182586.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000184324.11 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000185168.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000185837.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000186056.5 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000186148.7 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000186594.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000188365.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000188825.9 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000189223.9 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000197463.8 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000197558.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000197934.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000197989.9 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000203325.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000203496.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000203499.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000203499.6 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000203593.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000203635.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000203721.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000203849.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000203865.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000204044.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000204588.5 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000204666.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000204685.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000204860.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000205837.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000205885.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000205959.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000206129.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000206140.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000206176.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000206417.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000206417.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000206567.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000206573.4 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000212163.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000213742.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000213793.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000213994.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000213994.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000214049.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000214146.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000214353.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000214407.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000214432.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000214559.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000214725.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000214894.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000214955.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000215039.2 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000215068.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000215241.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000215244.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000215304.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000215394.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000215417.6 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000215769.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000215841.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000215866.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000219665.4 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000221817.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000222041.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000222044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000223356.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000223356.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000223379.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000223404.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000223477.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000223478.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000223502.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000223528.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000223573.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000223598.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000223665.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000223669.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000223695.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000223695.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000223725.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000223749.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000223749.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000223759.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000223791.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000223791.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000223813.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000223821.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000223829.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000223839.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000223884.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000223930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000223935.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000224017.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000224078.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000224081.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000224142.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000224165.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000224167.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000224292.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000224356.3 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000224394.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000224409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000224417.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000224429.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000224460.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000224481.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000224559.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000224592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000224596.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000224616.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000224638.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000224687.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000224789.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000224805.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000224812.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000224814.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000224818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000224846.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000224849.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000224888.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000224888.3 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000224905.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000224950.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000225030.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000225057.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000225075.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000225087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000225173.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000225195.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000225205.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000225205.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000225218.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000225234.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000225235.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000225279.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000225300.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000225361.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000225383.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000225407.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000225518.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000225521.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000225541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000225548.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000225548.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000225555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000225643.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000225721.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000225767.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000225783.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000225806.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000225850.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000225860.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000225880.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000225891.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000225891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000225931.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000225948.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000225963.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000225969.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000225969.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000225981.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000226026.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000226051.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000226125.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000226155.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000226245.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000226251.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000226251.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000226266.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000226287.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000226328.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000226328.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000226352.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000226367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000226377.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000226416.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000226419.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000226434.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000226445.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000226508.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000226637.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000226645.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000226648.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000226659.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000226711.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000226747.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000226803.3 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000226852.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000226864.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000226950.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000226963.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000227053.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000227060.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000227066.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000227070.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000227071.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000227076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000227076.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000227172.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000227188.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000227195.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000227210.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000227218.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000227248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000227279.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000227354.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000227372.6 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000227388.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000227431.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000227492.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000227496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000227512.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000227527.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000227533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000227627.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000227660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000227698.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000227704.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000227706.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000227719.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000227811.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000227906.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000227946.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000227946.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000227953.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000228010.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000228065.6 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000228072.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000228079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000228107.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000228124.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000228140.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000228223.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000228237.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000228237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000228274.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000228313.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000228386.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000228395.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000228397.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000228404.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000228463.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000228509.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000228509.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000228540.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000228544.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000228554.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000228596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000228604.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000228643.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000228649.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000228661.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000228723.2 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000228741.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000228784.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000228857.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000228857.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000228862.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000229140.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000229243.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000229278.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000229323.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000229368.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000229368.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000229404.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000229431.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000229484.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000229498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000229512.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000229512.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000229582.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000229647.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000229688.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000229692.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000229719.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000229727.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000229739.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000229766.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000229839.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000229852.2 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000229867.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000229915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000229950.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000229950.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000229953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000229964.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000229983.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000230002.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000230021.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000230046.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000230082.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000230090.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000230109.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000230174.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000230174.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000230212.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000230310.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000230424.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000230433.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000230439.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000230454.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000230470.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000230479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000230530.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000230550.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000230561.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000230565.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000230606.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000230648.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000230649.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000230658.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000230724.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000230732.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000230736.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000230825.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000230825.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000230826.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000230939.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000230990.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000231028.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000231028.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000231107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000231187.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000231249.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000231273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000231291.3 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000231329.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000231346.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000231363.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000231407.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000231439.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000231465.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000231486.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000231509.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000231521.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000231528.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000231536.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000231560.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000231563.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000231595.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000231595.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000231616.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000231638.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000231652.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000231663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000231703.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000231709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000231713.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000231728.2 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000231731.3 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000231760.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000231764.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000231811.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000231842.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000231890.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000231903.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000231908.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000231944.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000232023.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000232079.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000232098.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000232104.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000232118.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000232160.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000232224.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000232259.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000232274.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000232300.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000232311.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000232354.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000232406.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000232445.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000232480.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000232498.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000232533.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000232545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000232618.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000232633.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000232640.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000232648.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000232656.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000232656.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000232677.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000232677.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000232677.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000232679.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000232712.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000232759.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000232784.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000232788.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000232788.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000232788.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000232803.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000232803.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000232811.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000232827.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000232855.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000232907.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000232956.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000232973.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000233038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000233044.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000233048.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000233073.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000233093.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000233101.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000233178.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000233203.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000233244.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000233246.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000233303.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000233330.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000233396.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000233461.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000233554.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000233593.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000233593.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000233611.3 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000233613.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000233621.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000233625.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000233644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000233654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000233730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000233760.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000233806.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000233818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000233864.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000233895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000233926.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000233967.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000233967.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000234019.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000234193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000234233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000234264.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000234290.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000234361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000234393.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000234405.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000234432.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000234503.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000234504.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000234584.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000234601.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000234650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000234678.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000234753.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000234771.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000234771.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000234793.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000234817.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000234817.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000234848.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000234871.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000234884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000234915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000234917.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000234917.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000234996.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000235042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000235079.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000235091.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000235092.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000235092.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000235246.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000235257.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000235262.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000235298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000235326.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000235326.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000235373.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000235381.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000235387.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000235397.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000235427.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000235453.3 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000235481.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000235529.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000235530.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000235545.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000235560.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000235560.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000235586.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000235609.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000235635.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000235659.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000235702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000235760.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000235777.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000235795.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000235806.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000235831.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000235837.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000235852.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000235903.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000235910.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000235910.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000235989.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000235999.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000235999.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000235999.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000236003.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000236003.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000236017.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000236051.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000236095.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000236107.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000236130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000236137.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000236153.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000236204.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000236209.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000236234.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000236255.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000236336.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000236358.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000236364.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000236383.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000236393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000236394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000236426.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000236438.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000236467.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000236558.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000236591.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000236617.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000236703.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000236772.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000236772.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000236869.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000236869.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000236886.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000236889.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000236896.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000236908.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000236935.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000237017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000237017.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000237073.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000237126.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000237126.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000237149.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000237149.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000237187.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000237187.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000237222.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000237234.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000237248.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000237253.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000237280.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000237280.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000237291.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000237359.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000237371.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000237424.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000237429.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000237485.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000237485.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000237523.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000237548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000237687.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000237714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000237726.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000237737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000237737.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000237738.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000237738.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000237786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000237845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000237845.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000237852.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000237857.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000237857.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000237883.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000237899.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000237899.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000237934.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000237938.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000237940.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000237943.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000237976.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000238018.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000238018.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000238033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000238039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000238057.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000238113.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000238120.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000238123.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000238123.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000238140.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000238140.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000238160.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000238197.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000238197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000238197.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000238210.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000238221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000238290.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000239219.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000239219.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000239335.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000239377.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000239480.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000239523.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000239552.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000239677.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000239739.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000239801.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000239828.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000239906.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000240045.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000240057.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000240063.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000240086.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000240143.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000240373.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000240476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000240499.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000240618.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000240618.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000240996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000241269.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000241481.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000241520.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000241525.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000241599.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000241772.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000241818.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000241832.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000241860.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000241912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000241985.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000242094.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000242125.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000242154.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000242282.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000242516.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000242540.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000242628.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000242767.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000242767.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000242791.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000243018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000243083.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000243107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000243176.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000243230.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000243415.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000243433.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000243491.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000243637.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000243701.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000243795.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000243797.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000243960.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000244041.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000244055.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000244268.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000244380.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000244479.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000244578.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000244879.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000244879.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000244945.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000245059.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000245060.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000245060.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000245067.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000245080.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000245164.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000245213.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000245468.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000245479.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000245598.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000245648.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000245928.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000246016.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000246130.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000246130.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000246225.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000246228.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000246250.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000246334.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000246422.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000246465.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000246523.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000246526.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000246528.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000246582.2 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000246627.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000246731.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000246851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000246859.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000246876.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000246898.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000246898.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000247081.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000247131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000247131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000247228.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000247271.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000247324.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000247400.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000247516.3 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000247624.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000247699.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000247735.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000247809.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000247844.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000248092.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000248187.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000248187.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000248187.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000248206.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000248243.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000248254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000248318.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000248371.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000248473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000248476.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000248538.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000248559.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000248647.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000248664.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000248677.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000248714.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000248846.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000248846.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000248936.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000248968.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000249084.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000249456.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000249532.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000249550.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000249572.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000249602.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000249618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000249635.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000249673.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000249673.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000249685.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000249717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000249717.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000249738.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000249738.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000249787.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000249806.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000249825.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000249867.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000249996.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000250012.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000250043.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000250061.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000250101.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000250116.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000250129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000250131.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000250132.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000250260.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000250280.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000250284.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000250303.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000250337.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000250337.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000250410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000250413.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000250548.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000250551.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000250629.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000250635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000250714.3 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000250748.2 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000250786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000250790.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000250842.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000250909.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000250917.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000250958.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000251003.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000251015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000251018.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000251127.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000251136.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000251141.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000251143.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000251151.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000251161.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000251161.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000251221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000251221.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000251292.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000251301.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000251330.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000251331.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000251361.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000251364.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000251497.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000251523.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000251532.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000251556.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000251580.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000251615.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000251623.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000253121.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000253133.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000253369.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000253404.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000253406.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000253476.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000253477.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000253508.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000253508.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000253591.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000253603.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000253616.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000253618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000253653.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000253661.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000253669.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000253696.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000253712.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000253754.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000253766.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000253829.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000253829.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000253878.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000253893.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000253893.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000253921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000253925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000253948.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000253948.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000253972.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000253982.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000254034.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000254109.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000254119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000254154.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000254162.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000254205.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000254207.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000254219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000254231.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000254231.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000254266.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000254303.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000254314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000254315.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000254343.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000254343.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000254353.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000254363.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000254444.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000254451.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000254468.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000254477.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000254554.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000254602.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000254606.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000254607.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000254610.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000254682.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000254691.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000254718.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000254731.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000254756.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000254847.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000254854.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000254854.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000254855.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000254855.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000254859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000254990.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000255031.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000255045.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000255153.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000255159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000255182.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000255197.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000255237.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000255322.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000255326.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000255337.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000255343.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000255395.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000255418.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000255443.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000255471.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000255565.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000255644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000255669.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000255670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000255847.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000255893.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000255966.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000255968.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000255970.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000255992.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000256083.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000256139.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000256146.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000256268.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000256271.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000256299.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000256373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000256381.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000256576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000256615.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000256746.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000256789.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000256824.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000256904.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000257023.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000257027.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000257052.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000257139.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000257151.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000257151.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000257167.2 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000257261.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000257279.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000257346.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000257354.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000257381.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000257381.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000257381.2 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000257429.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000257475.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000257499.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000257499.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000257526.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000257548.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000257605.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000257636.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000257647.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000257647.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000257671.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000257718.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000257742.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000257808.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000257999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000258001.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000258017.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000258017.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000258044.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000258044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000258050.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000258057.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000258077.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000258137.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000258240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000258334.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000258344.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000258355.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000258410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000258451.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000258455.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000258473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000258479.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000258526.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000258535.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000258553.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000258593.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000258623.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000258646.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000258646.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000258657.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000258693.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000258701.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000258711.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000258725.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000258754.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000258798.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000258821.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000258827.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000258843.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000258858.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000258904.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000258904.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000258957.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000259002.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000259005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000259031.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000259069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000259146.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000259163.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000259187.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000259215.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000259215.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000259251.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000259251.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000259275.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000259283.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000259287.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000259294.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000259398.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000259402.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000259408.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000259416.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000259422.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000259448.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000259462.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000259475.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000259540.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000259548.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000259551.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000259583.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000259584.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000259590.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000259594.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000259606.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000259610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000259631.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000259652.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000259668.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000259687.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000259692.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000259712.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000259736.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000259755.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000259760.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000259767.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000259774.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000259782.2 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000259783.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000259783.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000259783.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000259797.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000259818.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000259826.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000259828.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000259840.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000259863.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000259863.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000259920.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000259933.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000259943.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000259972.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000260017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000260017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000260018.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000260025.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000260037.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000260049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000260051.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000260052.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000260060.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000260060.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000260065.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000260088.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000260100.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000260120.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000260132.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000260156.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000260160.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000260171.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000260185.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000260196.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000260231.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000260236.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000260269.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000260276.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000260310.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000260352.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000260361.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000260364.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000260368.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000260392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000260394.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000260394.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000260400.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000260404.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000260411.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000260416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000260447.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000260493.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000260528.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000260528.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000260536.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000260577.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000260579.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000260588.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000260589.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000260591.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000260604.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000260604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000260608.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000260630.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000260641.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000260647.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000260672.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000260708.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000260742.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000260766.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000260804.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000260814.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000260837.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000260841.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000260841.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000260891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000260895.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000260905.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000260910.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000260912.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000260930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000260938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000260953.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000260954.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000260955.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000260973.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000260986.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000261002.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000261024.2 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000261043.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000261079.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000261094.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000261101.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000261114.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000261117.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000261118.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000261123.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000261131.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000261183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000261195.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000261211.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000261252.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000261254.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000261254.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000261270.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000261273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000261291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000261329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000261342.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000261357.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000261366.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000261373.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000261399.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000261438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000261441.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000261469.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000261476.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000261513.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000261513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000261550.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000261550.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000261596.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000261597.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000261630.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000261646.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000261662.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000261690.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000261692.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000261693.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000261716.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000261723.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000261729.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000261758.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000261760.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000261777.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000261783.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000261799.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000261801.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000261829.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000261864.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000261872.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000261916.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000261924.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000262094.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000262098.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000262136.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000262172.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000262185.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000262188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000262265.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000262339.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000262362.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000262380.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000262380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000262410.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000262454.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000262454.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000262482.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000262580.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000262585.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000262619.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000262619.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000262693.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000262810.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000262873.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000262879.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000262952.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000262999.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000263063.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000263063.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000263080.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000263120.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000263214.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000263280.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000263293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000263470.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000263624.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000263624.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000263627.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000263727.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000263731.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000263731.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000263745.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000263745.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000263753.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000263766.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000263786.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000263859.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000263884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000263884.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000263916.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000263931.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000263934.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000264015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000264112.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000264188.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000264235.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000264235.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000264458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000264513.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000264647.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000264745.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000264859.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000265008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000265094.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000265334.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000265394.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000265394.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000265625.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000265692.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000265702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000265737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000265800.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000265962.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000266079.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000266088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000266088.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000266111.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000266126.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000266176.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000266176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000266278.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000266340.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000266371.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000266402.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000266456.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000266469.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000266717.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000266844.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000266896.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000266904.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000266911.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000266912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000266922.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000266930.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000266947.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000266950.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000266957.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000266970.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000266978.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000266983.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000266994.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000267006.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000267025.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000267025.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000267034.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000267057.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267058.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000267069.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267069.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000267069.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000267079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267104.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267108.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000267118.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000267128.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000267136.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000267138.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000267144.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000267151.2 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000267152.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267159.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000267163.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000267172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267191.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000267192.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000267201.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000267201.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000267212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000267219.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267243.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000267251.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267268.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000267274.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000267277.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000267280.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000267287.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000267308.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000267327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267342.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000267395.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267405.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000267479.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000267505.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000267505.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000267522.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267529.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000267581.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000267583.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000267588.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267612.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000267649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267649.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000267649.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000267651.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000267651.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267658.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000267662.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000267677.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000267690.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267712.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267731.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000267737.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000267750.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000267751.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000267778.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000267786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000267871.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000267886.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000267905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000267905.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000267986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000268015.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000268061.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000268081.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000268266.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000268333.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000268340.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000268340.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000268340.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000268375.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000268392.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000268392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000268401.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000268401.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000268499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000268516.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000268518.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000268520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000268543.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000268543.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000268549.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000268583.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000268584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000268601.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000268605.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000268613.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000268650.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000268686.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000268743.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000268746.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000268756.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000268764.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000268889.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000268913.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000268970.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000268970.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000268970.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000269082.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000269091.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000269148.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000269235.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000269386.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000269399.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000269400.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000269416.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000269463.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000269473.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000269481.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000269560.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000269574.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000269646.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000269652.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000269653.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000269696.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000269737.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000269814.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000269836.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000269873.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000269898.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000269898.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000269925.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000269927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000269938.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000269944.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000269951.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000269961.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000269967.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000269974.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000269983.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000269983.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000269990.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000269990.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000269997.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000270000.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000270001.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000270001.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000270019.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000270028.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000270028.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000270030.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000270031.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000270039.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000270055.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000270062.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000270068.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000270068.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000270072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000270072.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000270095.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000270109.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000270117.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000270127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000270130.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000270145.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000270154.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000270159.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000270174.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000270177.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000270178.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000270184.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000270210.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000270246.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000270419.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000270426.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000270457.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000270580.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000270599.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000270607.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000270640.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000270720.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000270760.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000270792.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000270949.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000271119.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000271200.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000271327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000271344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000271401.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000271555.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000271555.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000271584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000271646.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000271659.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000271722.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000271727.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000271743.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000271755.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000271757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000271780.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000271781.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000271781.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000271788.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000271825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000271845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000271857.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000271862.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000271871.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000271911.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000271912.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000271914.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000271914.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000271966.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000271978.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000271983.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000271992.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272003.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000272010.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000272023.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000272046.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272048.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272070.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000272076.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000272077.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000272086.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000272103.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000272103.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272108.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000272108.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000272138.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000272148.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000272161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272172.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272180.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000272181.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272183.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000272221.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000272226.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000272236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000272250.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000272254.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000272264.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000272288.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000272301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000272308.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000272312.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272324.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272327.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272343.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272373.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000272373.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000272374.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000272386.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000272417.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000272449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000272455.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000272468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272482.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000272529.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000272567.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000272567.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000272567.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000272627.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000272657.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272660.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000272663.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000272666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000272668.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000272672.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000272689.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000272707.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000272721.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000272734.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000272746.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000272755.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000272764.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000272769.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000272792.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000272792.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000272799.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000272825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000272846.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000272870.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000272871.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000272892.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000272905.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000272913.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000272914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000272933.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000272933.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000272953.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000272960.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000272989.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000272992.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000272993.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000272995.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000273004.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000273008.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000273015.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000273026.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000273027.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000273038.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000273038.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000273056.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000273065.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| KU-55933 |
ENSG00000273068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000273069.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000273077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000273081.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000273084.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000273091.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000273096.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000273100.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000273107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000273116.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000273123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000273160.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000273165.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| KU-55933 |
ENSG00000273165.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| KU-55933 |
ENSG00000273174.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000273186.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000273188.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000273230.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000273240.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| KU-55933 |
ENSG00000273257.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000273264.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000273281.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| KU-55933 |
ENSG00000273297.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000273297.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000273297.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| KU-55933 |
ENSG00000273308.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000273308.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000273311.1 |
Predicted lncRNA |
Sarcoma |
|
| KU-55933 |
ENSG00000273325.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| KU-55933 |
ENSG00000273329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| KU-55933 |
ENSG00000273335.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| KU-55933 |
ENSG00000273353.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000273365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| KU-55933 |
ENSG00000273406.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000273428.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000273454.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000273454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| KU-55933 |
ENSG00000273471.1 |
Predicted lncRNA |
Esophageal cancer |
|
| KU-55933 |
ENSG00000273472.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| KU-55933 |
ENSG00000273473.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| KU-55933 |
ENSG00000273483.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
